跳至主要内容
临床试验/NCT07404189
NCT07404189尚未招募不适用

Evaluation of the Acceptability and Clinical Effectiveness of Augmenting Comprehensive Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年8月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
300
试验地点
1
主要终点
Body Weight

研究概览

简要总结

This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive primary care-based behavioral obesity treatment program using a Zelen randomized controlled trial design.

详细描述

This pragmatic randomized clinical trial is conducted within the established FLOW program, a 12-month multidisciplinary behavioral obesity treatment aligned with USPSTF recommendations. Patients initiating FLOW are randomized to standard care or FLOW augmented with an offer of Nutu™, an AI-powered digital health platform providing behavioral support and self-monitoring tools. Outcomes are collected quarterly over 12 months using routinely collected clinical data.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients enrolled in the FLOW clinical program are eligible.

排除标准

  • Not a patient of the FLOW clinical program at UAB.

研究组 & 干预措施

Standard FLOW Program

Active Comparator

Participants receive the standard 12-month FLOW program including nutrition counseling, physician visits, and behavioral health support.

干预措施: FLOW Program (Behavioral)

FLOW + Nutu™ Offer

Experimental

Participants receive standard FLOW care and are offered access to the Nutu™ digital health platform, which may be accepted or declined.

干预措施: FLOW Program (Behavioral)

FLOW + Nutu™ Offer

Experimental

Participants receive standard FLOW care and are offered access to the Nutu™ digital health platform, which may be accepted or declined.

干预措施: Nutu™ Offer (Behavioral)

结局指标

主要结局

Body Weight

时间窗: Baseline to 12 months

Difference in body weight change between groups

次要结局

  • Nutu™ Acceptance(Baseline)
  • Nutu™ Engagement(Baseline through 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Drew Sayer

Assistant Professor

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验